Variant NM_000492.4:c.2538G>A
| Name | NM_000492.4:c.2538G>A |
| Protein name | NP_000483.3:p.(Trp846*) |
| Genomic name (hg19) | chr7:g.117235031G>A UCSC |
| Genomic name (hg38) | chr7:g.117594977G>A UCSC |
| #Exon/intron | exon 15 |
| Legacy Name | W846X (2670TGG>TGA) |
| Class | disease-causing |
| Subclass | CF-causing |
| WT sequence | AGAGCATACCAGCAGTGACTACATG G AACACATACCTTCGATATATTACTG |
| Mutant sequence | AGAGCATACCAGCAGTGACTACATG A AACACATACCTTCGATATATTACTG |
![]() |
![]() | dbSNP rs267606722 |
![]() Not found | ![]() |
| Reference | PMID | Modulator | in vitro / ex vivo data | clinical data | Patient responsiveness |
| Burgel et al., 2024 | 39151434 | ELX-TEZ-IVA | N.D. | yes | no |
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 34 |
|---|---|
| CF | 28 |
| CFTR-RD | 3
|
| Pending (NBS) | 3 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| CF | 319 | heterozygote | CF-causing - Trans |
| CF | 3751 | heterozygote | CF-causing- Undef |
| CF | 3784 | heterozygote | VUS3- Undef |
| CF | 3951 | heterozygote | CF-causing- Undef |
| CF | 3956 | heterozygote | CF-causing- Undef |
| CF | 4026 | heterozygote | CF-causing - Trans |
| CF | 4185 | heterozygote | CF-causing- Undef |
| CF | 6502 | heterozygote | varying clinical consequence- Undef |
| CF | 4298 | heterozygote | CF-causing- Undef |
| CF | 4364 | heterozygote | CF-causing - Trans |
| CF | 4365 | heterozygote | CF-causing - Trans |
| CF | 4441 | heterozygote | CF-causing - Trans |
| CF | 4442 | heterozygote | CF-causing - Trans |
| CF | 3747 | heterozygote | CF-causing- Undef |
| CF | 3725 | heterozygote | CF-causing - Trans |
| CF | 611 | heterozygote | CF-causing - Trans |
| CF | 6537 | heterozygote | CF-causing- Undef |
| CF | 1593 | heterozygote | CF-causing- Undef |
| CF | 5888 | heterozygote | CF-causing - Trans |
| CF | 2442 | heterozygote | CF-causing- Undef |
| CF | 2510 | heterozygote | CF-causing- Undef |
| CF | 3005 | heterozygote | CF-causing - Trans |
| CF | 3077 | heterozygote | CF-causing- Undef |
| CF | 3486 | heterozygote | CF-causing- Undef |
| CF | 3491 | heterozygote | CF-causing- Undef |
| CF | 3544 | heterozygote | CF-causing- Undef |
| CF | 3600 | heterozygote | CF-causing - Trans |
| CF | 4466 | heterozygote | CF-causing - Trans |
| CBAVD | 931 | heterozygote | CFTR-RD-causing - Trans |
| CBAVD | 1373 | heterozygote | |
| CBAVD | 2437 | heterozygote | CFTR-RD-causing- Undef |
| Pending (NBS) | 3771 | heterozygote | varying clinical consequence - Trans |
| Pending (NBS) | 3817 | heterozygote | varying clinical consequence - Trans |
| Pending (NBS) | 3872 | heterozygote | varying clinical consequence - Trans |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|